Page last updated: 2024-08-16

troglitazone and bisbenzimidazole

troglitazone has been researched along with bisbenzimidazole in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Oshitani, N; Sasaki, E; Takashima, T; Tominaga, K; Watanabe, T	1

Other Studies

1 other study(ies) available for troglitazone and bisbenzimidazole

Article	Year
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. Oncology reports, 2005, Volume: 13, Issue:4 Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Esophageal Neoplasms; G1 Phase; Humans; Immunohistochemistry; Ligands; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Thiazolidinediones; Thymidine; Troglitazone	2005

Article

Year

Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.

Oncology reports, 2005, Volume: 13, Issue:4

Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Esophageal Neoplasms; G1 Phase; Humans; Immunohistochemistry; Ligands; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Thiazolidinediones; Thymidine; Troglitazone

2005